Avalo Therapeutics Inc. – Investors and Politicians Who Own It
AVTX, 2 share classes and securities
Investors who own it
8 tracked investors, $230.3M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
David KroinDeep Track Capital, Q2 2026 | $66.7M | 0.97% |
Farallon Capital ManagementQ2 2026 | $46.2M | 0.21% |
Behzad AghazadehAvoro Capital Advisors, Q2 2026 | $43.1M | 0.39% |
Mark LampertBVF Partners, Q2 2026 | $38.4M | 0.98% |
Peter KolchinskyRA Capital Management, Q2 2026 | $18.5M | 0.16% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $10.2M | 0.05% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $4.1M | 0.06% |
Rod WongRTW Investments, Q2 2026 | $3.2M | 0.03% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Reduced −34% | 567,103 |
| Joseph Edelman | Reduced −73% | 139,667 |
| Mark Lampert | Reduced −0.8% | 1,028,049 |
| Peter Kolchinsky | Reduced −3.5% | 932,973 |
| Daniel Schneeberger | Added +947% | 104,730 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.